Entitelmi Tablet 80 mg (Telmisartan)

Adult dose

Essential Hypertension: It is recommended to orally administer 40 mg of telmisartan once daily; based on patient response, 20 mg once daily may be effective. If necessary, the dose can be increased up to 80 mg once daily. Risk reduction for cardiovascular diseases: It is recommended to orally administer 80 mg of this medication once daily. Liver impaired patients: In patients with mild to moderate liver impairment, the daily dosage should not exceed 40 mg.

This medication can cause serious harm to the fetus and newborns, especially during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Individuals with allergies to this medication or its components, pregnant or nursing women, patients with severe liver impairment, and those with hereditary angioedema should not use it. Caution should be exercised when administering this medication to the elderly, patients with hyperkalemia, mild to moderate liver impairment, and those with heart diseases; special care is required for patients with poor kidney function. During use, regular monitoring of blood pressure, kidney function, and serum potassium levels should be performed to detect any abnormal signs early. While this medication effectively lowers blood pressure, various side effects such as dizziness, headache, abdominal pain, skin rash, and myalgia may occur; if any unusual symptoms arise, consult a healthcare professional immediately. Particularly, if symptoms of angioedema appear, there is a risk of respiratory distress, so treatment should be stopped immediately and emergency measures taken. When taking this medication with other antihypertensives, specific diuretics, potassium supplements, or non-steroidal anti-inflammatory drugs (NSAIDs), interactions may occur, so a consultation with a doctor is necessary. This medication is not removed by dialysis, and there is no specific antidote in case of overdose; suitable treatment should be administered based on the symptoms. Safety and efficacy in children have not been established, and it should be administered cautiously in the elderly to avoid excessive blood pressure reduction. This medication contains sorbitol; those with fructose intolerance should be cautious, and dizziness or drowsiness may occur while driving or operating machinery, so proceed with caution.

Serious side effects

Urticaria, severe swelling (edema), angioedema, anaphylactic reactions, severe skin reactions (toxic skin rash, toxic skin lesions), respiratory distress, liver abnormalities (jaundice), sudden and severe headache, paralysis, rhabdomyolysis, acute renal failure, shock, loss of consciousness, syncope due to hypotension, liver function impairment, laryngeal edema, symptoms resembling anaphylaxis, interstitial pneumonia

Mild side effects

• Upper respiratory tract infection
• urinary tract infection
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia
• hypoglycemia
• depression
• insomnia

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The recommended storage temperature is between 1 and 30 degrees Celsius at room temperature. Proper storage ensures the safety of the medication's effectiveness.

Appearance

White oval tablets

Package unit

30 tablets (10 tablets/AluAlu*3)